Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3033 |
|
Actual shortage: | 243 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2023-02-23 | 2023-03-02 | 185471 |
APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2023-02-23 | 2023-03-23 | 185492 |
APO PIROXICAM CAP 20MG | 20MG | CAPSULE | Resolved | 2023-03-16 | 2023-03-23 | 187232 |
APO-DABIGATRAN | 150MG | CAPSULE | Resolved | 2023-04-14 | 2023-06-08 | 189659 |
APO-CEFADROXIL | 500MG | CAPSULE | Resolved | 2023-04-21 | 2024-03-08 | 190008 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-05-19 | 2023-07-27 | 192806 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-06-02 | 2023-07-07 | 193600 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2023-07-21 | 2024-01-05 | 199518 |
APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2023-07-21 | 2023-08-18 | 199524 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-08-12 | 2023-08-18 | 201696 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2023-09-01 | 2023-10-20 | 203560 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-09-15 | 2023-10-06 | 204420 |
APO-RIVASTIGMINE | 3MG | CAPSULE | Resolved | 2023-09-28 | 2024-01-05 | 205501 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
APO-LENALIDOMIDE | 20MG | CAPSULE | Resolved | 2023-10-20 | 2023-12-01 | 207695 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-10-20 | 2023-11-10 | 207719 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-11-10 | 2024-01-19 | 209945 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-17 | 2024-01-12 | 210683 |
APO-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2023-12-08 | 2023-12-15 | 212937 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |